EQT/Zeus
Transaction details
The proposed acquisition of indirect sole control of Zeus Company Inc. by EQT Fund Management S.à r.l, acting as fund manager for and on behalf of the entities forming the investment fund EQT X has been cleared by the Competition and Consumer Protection Commission.
Case details
- Notification date:4 January 2024
- Publication date:4 January 2024
- Economic sector:Manufacturing - C
- Economic sub-sector:Manufacturing of rubber and plastic - C.22
- Simplified merger:Yes
- Outcome:Cleared
Documents
M/24/001 Merger AnnouncementPDF | 109 KBM/24/001 Merger Announcement PDF | 109 KB - Opens in new window
M/24/001 DeterminationPDF | 145 KBM/24/001 Determination PDF | 145 KB - Opens in new window
Timetable
Parties Involved
EQT Fund Management S.à r.l.
EQT Fund Management S.à r.l. ("EFMS") acts as fund manager for and on behalf of the entities forming the investment fund EQT X.
EQT X
EQT X consists of a group of private equity funds that invests in portfolio companies in Europe, Asia, and the US, and is active in a variety of industries.
Zeus Company Inc.
Zeus Company Inc. ("Zeus") is a medical technology company involved in the global supply of polymer solutions, including tubing, catheter componentry, heat shrinks, bioabsorbable and implantable medical products, sutures, and fiber optics, for a number of applications, predominantly in medical, but including some activities in aerospace, automotive, and energy. In the State, Zeus operates a manufacturing plant in Letterkenny, County Donegal.
Contacts
Louis O'Carroll louisocarroll@ccpc.ie
